Диссертация (1141228), страница 21
Текст из файла (страница 21)
Task Force for Advanced BleedingCare in Trauma Management of bleeding following major trauma: a Europeanguideline. Crit Care. 2007;11:R17.137. Spyropoulos A.C., Douketis J.D. How I treat anticoagulated patients undergoing an elective procedure or surgery. Blood 2012; 120:2954.138. Stein P.D., Hull R.D., Matta F., Yaekoub A.Y. Anticoagulant therapy foracute venous thromboembolism: what we think we know and what the data showfor the timing of recurrent events. Clin Appl Thromb Hemost 2009, 15:609-612.120139. Takahashi H., Echizen H. Pharmacogenetics of warfarin elimination and itsclinical implications. Clin Pharmacokinet 2001;40:587-603.140.
Taube J., Halsall D., Baglin T. Influence of cytochrome P- 450 CYP2C9polymorphisms on warfarin sensivity and risk of over- anticoagulation in pa-tientson long- term treatment. Blood. 2000; 96 (5): 1816- 9.141. D. F. O'Shaughnessy., C. Atterbury., P. Bolton Maggs., M. Murphy., D.Thomas., S. Yates., L.
M. Williamson. Guidelines for the use of fresh-frozenplasma, cryoprecipitate and cryosupernatant. British Committee for Standards inHaematology, Blood Transfusion Task Force. British Journal Society ofHaematology, 2004, 11-28.142. Thijssen H.H., Soute B.A., Vervoort L.M. et al. Paracetamol (acetaminophen) warfarin interaction: NAPQI, the toxic metabolite of paracetamol, is aninhibitor of enzymes in the vitamin K cycle. Thromb Haemost 2004;92:797-802.143. Torn M., Rosendaal F.R. Oral anticoagulation in surgical procedures: risksand recommendations. Br J Haematol 2003; 123:676.144.
Trujillo-Santos J., Ruiz-Gamietea A., Luque J.M., Samperiz A.L., Gar-ciaBragado F., Todoli J.A. et al. Predicting recurrences or major bleeding in womenwith cancer and venous thromboembolism. Findings from the RIETE Registry.Thromb Res 2009, 123(2):S10-S15.145. Viguè B. Bench-to-bedside review: optimising emergency reversal of vitamin K antagonists in severe haemorrhage – from theory to practice. Crit Care.2009;13:209.146.
Vrigina A., Julien C., Soly F. et al. Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery. Interactive Cardio Vascular andThoracic Surgery. 2012; 15: 382- 9.147. Walker I.D. In: Greer I.A. Bailliere's clinical obstetrics and gynaecolo-gythromboembolic disease in obstetrics and gynaecology. London: Bailliere Tindall,1997; 431-45.121148. Wells P.S., Holbrook A.M., Crowther N.R., Hirsch J.
Interactions of warfarin with drugs and food. Ann Intern Med. 1994;121:676–83.149. White R.H. The epidemiology of venous thromboembolism. Circulation.2003; 107 (Suppl I): I-4–I-8.150. Yasaka M., Oomura M., Ikeno K. Et al. Effect of prothrombin complexconcentrate on INR and blood coagulation system in emergency patients treat-edwith warfarin overdose.
Ann. Hematol. 2003; 82:121-123..